What is Revelation Biosciences Inc's share price today?
Revelation Biosciences Inc (REVB) share price today is $1.00 as of September 5, 2026 at 1:30 AM IST. The stock touched a day high of $1.02 and a day low of $1.00.What exchange does Revelation Biosciences Inc stock trade on, and under what ticker symbol?
Revelation Biosciences Inc stock trades on NASDAQ under the ticker symbol REVB.What is Revelation Biosciences Inc's market capitalization?
Revelation Biosciences Inc's market capitalization is $3.64M as of September 5, 2026 at 1:30 AM IST.What is Revelation Biosciences Inc's price-to-earnings (P/E) ratio?
Revelation Biosciences Inc's price-to-earnings (P/E) ratio is 0.00 as of September 4, 2026.What is Revelation Biosciences Inc's price-to-book (P/B) ratio?
Revelation Biosciences Inc's price-to-book (P/B) ratio is 0.93 as of September 4, 2026.Can Indian investors buy Revelation Biosciences Inc shares?
Yes, You can buy Revelation Biosciences Inc shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.How can I invest in Revelation Biosciences Inc shares from India?
Indian investors can buy Revelation Biosciences Inc shares in three steps: 1. Search Revelation Biosciences Inc on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.How does USD-INR currency movement affect returns from Revelation Biosciences Inc shares for Indian investors?
Since Revelation Biosciences Inc trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.What is the minimum amount required to invest in Revelation Biosciences Inc shares via Tickertape?
Indian investors can start investing in Revelation Biosciences Inc (REVB) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 9.9304 shares at the current price of $1.00.
$
₹
$1.00—% (+1.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
1D
1W
1M
1Y
5Y
Max
Key Metrics
Key Metrics
PE TTM
PE TTM
Close price divided by the earnings per share for the trailing twelve months
0.00
PB
PB
Close price divided by the book value per share at the end of the most recent quarter
0.93
EPS TTM
EPS TTM
Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)
$325
PEG Ratio
PEG Ratio
Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years
—
Profit Margin
Profit Margin
Net profit divided by the total revenue for the most recent financial year
0%
Dividend Yield
Dividend Yield
Annual dividend per share for the trailing twelve months divided by the close price
—
Analyst Ratings & ForecastAnalyst Ratings & Forecast
Analyst Ratings & Forecast
Analyst Ratings & Forecast
Based on 1 analyst's reports
Buy1 analyst
Hold0 analyst
Sell0 analyst
Analysts expect a +6196.30% price upside over the next year
Current Price$1.00
Target Price$85
Company Profile
Peers
Peers
ABBV
—
—
P/E Ratio
73.51
73.51
—
—
1Y Return
24.42%
24.42%
Buy Reco %
57.14
57.14
AMGN
—
—
P/E Ratio
27.25
27.25
—
—
1Y Return
57.12%
57.12%
Buy Reco %
46.87
46.87
—
—
P/E Ratio
—
—
—
—
1Y Return
33.32%
33.32%
Buy Reco %
63.33
63.33
—
—
P/E Ratio
31.85
31.85
—
—
1Y Return
40.67%
40.67%
Buy Reco %
52.94
52.94
—
—
P/E Ratio
20.36
20.36
—
—
1Y Return
49.79%
49.79%
Buy Reco %
76.00
76.00
Peers & Comparison
Peers & Comparison
Valuation
Returns
Forecast
| Stock | PE TTMPE TTM | PBPB | PEG RatioPEG Ratio |
|---|---|---|---|
| Revelation Biosciences Inc | 0.00 | 0.93 | - |
| AbbVie Inc | 73.51 | 50.45 | 0.36 |
| Amgen Inc | 27.25 | 20.26 | 2.10 |
Price Comparison
Price Comparison
1 Month
1 Year
5 Years
Financials
Financials
Income
Balance Sheet
Cash Flow
Quarterly Normal View